Open Access. Powered by Scholars. Published by Universities.®
Pharmacy Administration, Policy and Regulation Commons™
Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Health Law and Policy (4)
- Social and Behavioral Sciences (4)
- Food and Drug Law (3)
- Health Policy (2)
- Public Affairs, Public Policy and Public Administration (2)
-
- Public Health (2)
- Administrative Law (1)
- Agency (1)
- Community Health (1)
- Consumer Protection Law (1)
- Economics (1)
- Health Economics (1)
- Medical Jurisprudence (1)
- Mental and Social Health (1)
- Other Political Science (1)
- Other Public Health (1)
- Patient Safety (1)
- Pharmaceutics and Drug Design (1)
- Political Science (1)
- Quantitative, Qualitative, Comparative, and Historical Methodologies (1)
- Sociology (1)
- Substance Abuse and Addiction (1)
- Torts (1)
- Keyword
-
- Addiction care (1)
- Administrative waiver (1)
- Competition (1)
- Corporate influence (1)
- Deference to physicians (1)
-
- Drug compounding (1)
- FDA (1)
- Federalism (1)
- Fiscal fragmentation (1)
- Food and Drug Administration (1)
- Fraud (1)
- Health insurance plans (1)
- Medical malpractice (1)
- Narcotic Addict Treatment Act (1)
- Opioid addiction (1)
- Opioids (1)
- Patient safety (1)
- Pharmacy networks (1)
- Prescription drug costs (1)
- Prescription drugs (1)
- Reform (1)
- Regulatory failure (1)
- Regulatory oversight (1)
- State-based regulatory regime (1)
- Substance Use Disorder (1)
- Tort law (1)
Articles 1 - 5 of 5
Full-Text Articles in Pharmacy Administration, Policy and Regulation
Customary Corruption, Ani B. Satz, Liza Vertinsky
Customary Corruption, Ani B. Satz, Liza Vertinsky
Faculty Articles
For over a hundred years, it has been well-accepted among tort scholars that physicians—as one of the legally recognized professions— determine their own customary practices. Within tort law, and medical malpractice more specifically, customary practice establishes whether physicians breach or uphold the required standard of care toward their patients. The results of our hand-coded examination of decided cases and statutes show a more complex picture. While some states have endeavored to shift the standard away from professional custom, it continues to play a critical, and in many cases a determinative, role in establishing physician liability in most states.
Using illustrative …
Defederalizing Opioid Addiction Care, Matthew B. Lawrence
Defederalizing Opioid Addiction Care, Matthew B. Lawrence
Faculty Articles
Lack of access to evidence-based care for drug addiction is an urgent problem amid a decades-long overdose crisis that kills tens of thousands of Americans a year. Opioid addiction is the primary driver of overdoses today, and medicines exist to treat such addiction that can dramatically improve quality of life while reducing the risk of deadly overdose by more than half. Yet fewer than one in four of the nine million Americans who need such evidence-based medical care for their addiction receive it. Chief among barriers to access are restrictive and burdensome federal requirements limiting the use of narcotic medications …
Reflections On The Effects Of Federalism On Opioid Policy, Matthew B. Lawrence
Reflections On The Effects Of Federalism On Opioid Policy, Matthew B. Lawrence
Faculty Articles
One thing we have seen today that we talk about in health law all the time is how the policy, the laws and institutions up at the 10,000 foot level, can so dramatically influence the personal, people’s lived experiences. Our speakers today have done a really great job of drawing out abstract institutional questions and also showing us how those questions have influenced the lives of real people in often tragic ways. Another thing we have seen that we talk about in administrative law all the time is the importance of expertise, especially given how hard it is to trace …
Regulatory Gaps In Drug Compounding: Implications For Patient Safety, Innovation, And Fraud, Joanna Shepherd
Regulatory Gaps In Drug Compounding: Implications For Patient Safety, Innovation, And Fraud, Joanna Shepherd
Faculty Articles
Drug compounding is the practice of mixing, combining, or altering drug ingredients to create a product that meets the medical needs of a patient whose needs cannot otherwise be met with commercially-available products. Compounding is essential for patients that are allergic to certain ingredients or cannot tolerate the route of administration or dosage form of a commercially-available drug. Compounding may also enable pharmacists to supply medications when there is a shortage of commercially-available drugs. For example, amid the nationwide shortage of generic liquid Tamiflu and growing flu deaths in early 2018, pharmacists around the country used Tamiflu capsules to compound …
Selective Contracting In Prescription Drugs: The Benefits Of Pharmacy Networks, Joanna Shepherd
Selective Contracting In Prescription Drugs: The Benefits Of Pharmacy Networks, Joanna Shepherd
Faculty Articles
Selective contracting in health care involves contractual arrangements among insurers and health care providers that give covered individuals a financial incentive to obtain health care from a limited panel of providers. Although selective contracting has been an important strategy of health insurance plans for decades, it has only recently expanded to prescription drug coverage. Drug plans now create pharmacy networks that channel customers to in-network pharmacies. Pharmacies compete to be part of the networks by offering discounts on the drugs they sell to covered customers and drug plans. Although networks can lower prescription drug costs for drug plans and consumers, …